CNS & Neurological Disorders - Drug Targets

Formerly Current Drug Targets - CNS & Neurological Disorders


Edoardo Spina
Department of Clinical and Experimental Medicine
University of Messina
Policlinico Universitario
Via Consolare Valeria

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 16 Issue: 4, May 2017

Meet Our Editorial Board Member free to download

Volume:16   Issue: 4
Pp: 369-369
Laszlo Siklos*
DOI: 10.2174/187152731604170705191853
Published on: 05 July, 2017

The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents

Volume:16   Issue: 4
Pp: 370-379
Eric Murillo-Rodriguez*, Jose Carlos Pastrana-Trejo, Mireille Salas-Crisóstomo and Miriel de-la-Cruz
DOI: 10.2174/1871527316666170223161908
Published on: 23 February, 2017

Dopaminergic Modulation of Sleep-Wake States

Volume:16   Issue: 4
Pp: 380-386
Andrea Herrera-Solis, Wendy Herrera-Morales, Luis Nunez-Jaramillo and Oscar Arias-Carrion*
DOI: 10.2174/1871527316666170320145429
Published on: 20 March, 2017

Neuroprotective Effects of Citrus Fruit-Derived Flavonoids, Nobiletin and Tangeretin in Alzheimer's and Parkinson's Disease

Volume:16   Issue: 4
Pp: 387-397
Nady Braidy*, Sahar Behzad, Solomon Habtemariam, Touqeer Ahmed, Maria Daglia, Seyed Mohammad Nabavi, Eduardo Sobarzo-Sanchez and Seyed Fazel Nabavi
DOI: 10.2174/1871527316666170328113309
Published on: 28 March, 2017

Immune System Modulators with Antidepressant Effects: Evidence from Animal Models

Volume:16   Issue: 4
Pp: 398-406
Helena M. Abelaira, Amanda L. Maciel, Joao Quevedo and Gislaine Z. Reus*
DOI: 10.2174/1871527316666170404141620
Published on: 04 April, 2017

Alzheimer's Disease and the Routine Clinical Use of CSF Biomarkers

Volume:16   Issue: 4
Pp: 407-413
Alessandro Martorana*
DOI: 10.2174/1871527316666170124164854
Published on: 24 January, 2017

Utilizing Delta Opioid Receptors and Peptides for Cytoprotection: Implications in Stroke and Other Neurological Disorders

Volume:16   Issue: 4
Pp: 414-424
Marci G. Crowley, M. Grant Liska, Trenton Lippert, Sydney Corey and Cesar V. Borlongan*
DOI: 10.2174/1871527316666170320150659
Published on: 20 March, 2017

Monoamine Oxidase B Inhibitors in Parkinson's Disease

Volume:16   Issue: 4
Pp: 425-439
Livia Dezsi and Laszlo Vecsei*
DOI: 10.2174/1871527316666170124165222
Published on: 24 January, 2017

Abnormalities in Kynurenine Pathway Metabolism in Treatment-Resistant Depression and Suicidality: A Systematic Review

Volume:16   Issue: 4
Pp: 440-453
Gianluca Serafini*, Giulia Adavastro, Giovanna Canepa, Laura Capobianco, Claudia Conigliaro, Federica Pittaluga, Martino Belvederi Murri, Alessandro Valchera, Domenico De Berardis, Maurizio Pompili, Daniel Lindqvist, Lena Brundin and Mario Amore
DOI: 10.2174/1871527316666170413110605
Published on: 13 April, 2017

Suicide Prevention in Schizophrenia: Do Long-Acting Injectable Antipsychotics (LAIs) have a Role?

Volume:16   Issue: 4
Pp: 454-462
Maurizio Pompili*, Laura Orsolini, Dorian A. Lamis, David R. Goldsmith, Adele Nardella, Giulia Falcone, Valentina Corigliano, Mario Luciano and Andrea Fiorillo
DOI: 10.2174/1871527316666170223163629
Published on: 23 February, 2017

Therapeutic Role of Synaptic Vesicle Glycoprotein 2A (SV2A) in Modulating Epileptogenesis

Volume:16   Issue: 4
Pp: 463-471
Yukihiro Ohno* and Kentaro Tokudome
DOI: 10.2174/1871527316666170404115027
Published on: 04 April, 2017

IgA/IgM Responses to Gram-Negative Bacteria are not Associated with Perinatal Depression, but with Physio-somatic Symptoms and Activation of the Tryptophan Catabolite Pathway at the End of Term and Postnatal Anxiety

Volume:16   Issue: 4
Pp: 472-483
Chutima Roomruangwong*, Buranee Kanchanatawan, Sunee Sirivichayakul, George Anderson, Andre F. Carvalho, Sebastien Duleu, Michel Geffard and Michael Maes*
DOI: 10.2174/1871527316666170407145533
Published on: 07 April, 2017

Parkinson's Disease is Accompanied by Intertwined Alterations in Iron Metabolism and Activated Immune-inflammatory and Oxidative Stress Pathways

Volume:16   Issue: 4
Pp: 484-491
Carine Coneglian de Farias, Michael Maes*, Kamila Landucci Bonifacio, Andressa Keiko Matsumoto, Chiara Cristina Bortolasci, Andre de Souza Nogueira, Francis Fregonesi Brinholi, Helena Kaminami Morimoto, Lucio Baena de Melo, Estefania Gastaldello Moreira and Decio Sabbatini Barbosa
DOI: 10.2174/1871527316666170223161004
Published on: 23 February, 2017

Further Evaluation of Mechanisms Associated with the Antidepressantlike Signature of Scopolamine in Mice

Volume:16   Issue: 4
Pp: 492-500
Anna E. Martin, Douglas A. Schober, Alexander Nikolayev, Vladimir V. Tolstikov, Wesley H. Anderson, Richard E. Higgs, Ming-Shang Kuo, Anastasia Laksmanan, John T. Catlow, Xia Li, Christian C. Felder* and Jeffrey M. Witkin*
DOI: 10.2174/1871527316666170309142646
Published on: 09 March, 2017

Clinically Relevant Drug Interactions with Anti-Alzheimer's Drugs

Volume:16   Issue: 4
Pp: 501-513
Filippo Caraci*, Janet Sultana, Filippo Drago and Edoardo Spina
DOI: 10.2174/1871527316666170303144817
Published on: 03 March, 2017

Elevated C-reactive Protein Levels in Women with Bipolar Disorder may be Explained by a History of Childhood Trauma, Especially Sexual Abuse, Body Mass Index and Age

Volume:16   Issue: 4
Pp: 514-521
Juliana Brum Moraes*, Michael Maes, Decio Sabbatini Barbosa, Thais Zagabria Ferrari, Marcela Keikko Spagolla Uehara, Andre F. Carvalho and Sandra Odebrecht Vargas Nunes
DOI: 10.2174/1871527316666170407151514
Published on: 07 April, 2017